Paricalcitol Independently Increases Hemoglobin Levels
Paricalcitol, a selective vitamin D receptor activator, increases hemoglobin levels, including in patients without chronic kidney disease (CKD) or secondary hyperparathyroidism (SHPT). Investigators reported the new findings in a poster presentation at the American Society of Nephrology’s Kidney Week 2022 meeting in Orlando, Florida. “These results represent a real opportunity for exploring the use of paricalcitol […]
Paricalcitol Independently Increases Hemoglobin Levels Read More »
